I6T-MC-AMAP
| abstract | A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis LUCENT 3 |
| type of project | clinical studies |
| status | scheduled |
| start of project | 2021 |
| end of project | 2024 |
| responsible person | Dr. Prof. Stephan Brand |